Journals / Göztepe Tıp Dergisi / 2006 / Cilt: 21 - Sayı: 3

Effect of valproic acid usage on serum lipid profile in patients with epilepsy

Epilepsi hastalarında valproik asid kullanımının serum lipid profilleri üzerine etkisi

Pages
142–144
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

So that we agreed that serum lipid profile must be regularly measured in patients using VPA

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The effect of antiepileptic drugs on serum lipid concentrations is well known.
📊
Key Findings & Data:We investigate the effect of VPA usage on lipid profile.Serum lipid profiles of 25 epileptic patients followed with the VPA mono treatment and a control group consisting of 25 cases with similar sex ratio and ages were measured.The age and sex ratio of the cases in VPA using group and control group were not significantly different.
💡
Conclusion & Impact:So that we agreed that serum lipid profile must be regularly measured in patients using VPA
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The effect of antiepileptic drugs on serum lipid concentrations is well known. We investigate the effect of VPA usage on lipid profile.Serum lipid profiles of 25 epileptic patients followed with the VPA mono treatment and a control group consisting of 25 cases with similar sex ratio and ages were measured.The age and sex ratio of the cases in VPA using group and control group were not significantly different. According to control group it is detected that VPA usage has no effects on lipid profile. In the group of patients on VPA treatment, TK, HDL-C, LDL-C, VLDL-C, TG, TK/HDL and LDL/HDL levels were not affected from age, gender, serum level of VPA and the dose and duration of VPA treatment.Conclusion: Because different results were reported in several reports about the effect of VPA on serum lipid profile, which must be used in long term period for the treatment of epilepsy, no consensus has been made. So that we agreed that serum lipid profile must be regularly measured in patients using VPA

Özet

Antiepileptik ilaçların serum lipid konsantrasyonlarını etkilediği bilinir. Biz de valproik asid (VPA) kullanımının lipid profiline etkisini araştırdık.Epilepsi nedeniyle izlenen ve monoterapi olarak VPA kullanan 25 epileptik hasta ve yaş-cins olarak benzer 25 kontrol grubunda serum lipid profilleri seviyeleri ölçüldü.VPA kullanan ve kontrol gurubundaki olgular yaş ve cinsiyet açısından incelendiğinde anlamlı bir fark yoktu. Kontrollerle karşılaştırıldığında, VPA kullanımının serum lipid profili üzerinde değişikliğe neden olmadığı saptandı. VPA tedavisi alan grupta, TK, HDL-C, LDL-C, VLDL-C, TG, TK/HDL ve LDL/HDL değerlerinin yaş, cinsiyet, VPA'in serum düzeyi, dozu ve kullanım süresinden etkilenmediği saptandıEpilepsi tedavisinde uzun süreli kullanılması gereken VPA'in, serum lipid profili üzerine etkilerini gösteren farklı sonuçlar bildirildiğinden henüz bir fikir birliği yoktur. Bundan dolayı, VPA kullanan hastaların serum lipidlerinin belirli aralıklarla kontrol edilmesi gerektiği kanısındayız.

🔖

Cite This Article

SANGÜN, Ö., DUMAN, T., MELEK, İ., İNCECİK, F. (2022). Effect of valproic acid usage on serum lipid profile in patients with epilepsy. Göztepe Tıp Dergisi, Cilt: 21 - Sayı: 3, 142–144. https://ajindex.com/articles/526333

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. EirisPunal J, Del Rio Garına M, Del RıoGarma MC, et al: Longterm treatment of children with epilepsy with valproate or carbamazepine may cause subclinical hypothyroidism. Epilepsia 40:1761-1766, 1999
  2. Feldkamp J: Long-term anticonvulsant therapy leads to low bone mineral densityevidence for direct drugs effects of phenytoin and carbamazepine on human osteoblastlike cells. Exp Clin Endocrinol Diabetes 108:3743, 2000
  3. Verotti A, Domizio S, Angelozzi B, et al: Changes in serum lipids and lipoproteins in epileptic children treated with anticonvulsants. J Pediatr Child Health 33:2425, 1997
  4. Eiris JM, Lojo S, Del Rio MG, et al: Efects of long-term treatment with antiepileptic drugs on serum lipid levels in children with epilepsy. Neurology 45:1155-1157, 1995
  5. Franzoni E, Descovich GC, Salvioli GP; Total cholesterol, high density lipoprotein and triglycerides in children receiving antiepileptic drugs. Epilepsia 33:932-935, 1992
  6. Demircioğlu S, Soylu A, Dirik E: Carbamazepine and valproic acid: Effects on the serum lipids and liver functions in children. Pediatric Neurology 23:1426, 2000
  7. Reddy MN: Effect of anticonvulsant drugs on plasma total cholesterol, high-density lipoprotein cholesterol, and apolipoproteins A and B in children with epilepsy. Proc Soc Exp Biol Med 180:359-363,1985
  8. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 30:389-399, 1989
  9. Newman WP, Friedman DS, Voors AW: Relation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis: the Bogalusa Heart Study. New Engl J Med 314:138-144, 1986
  10. Muuronen A, Kaste M, Nikkila EA, et al: Mortality from ischemic heart disease among the patients using anticonvulsant drugs: A case control study. BMJ 291:1481-1483, 1985
  11. Zeilthoper S, Doppelbauer A, Tribl G, et al: Changes in serum lipid pattern during long term anticonvulsant treatment. Clin Invest 71:574-578, 1993
  12. Nikolaos T, Stylianos G, Chryssoula N, et al: The effect of long-term antiepileptic treatment on serum cholesterol (TC, HDL, LDL) and triglyceride levels in adult epileptic patients on monotherapy. Med Sci Monit 10:50-52, 2004
  13. Sozuer DT, Atakil D, Doğu O, et al: Serum lipids in epileptic children treated with carbamazepine and valproate. Eur J Pediatr 156:565-567, 1997
  14. Yilmaz E, Dosan Y, Gurgoze MK, et al: Serum lipid changes during anticonvulsiv